Interlynk

Interlynk, founded in 2022 and based in Menlo Park, California, builds a SaaS platform that automates software bill of materials (SBOM) collection across the software development lifecycle, connecting build pipelines for automated generation and tracking open-source license and component health. Its positioning leans heavily on regulatory compliance: FDA 524B for medical devices, the EU Cyber Resilience Act, IEC 62304, PCI DSS 4.0, and DORA.

Its clearest customer evidence is in medical devices, where BIOTRONIK engaged Interlynk for SBOM generation, vulnerability reporting, and open-source risk assessment ahead of FDA cybersecurity requirements. Other disclosed customers include OwnersBox, a fantasy sports platform, for PCI DSS compliance, and Empo Health, a remote diabetic care company. The company also maintains open-source SBOM tooling — sbomqs, sbomasm, and sbomgr — that it says is used by security teams and government agencies independent of its paid product, and it sells through AWS Marketplace.

Interlynk’s differentiation is a narrow, compliance-driven focus rather than a broad application security platform — it is betting that regulatory deadlines like the FDA’s 524B and the EU CRA will force SBOM automation to become a line-item requirement rather than a nice-to-have. The company has not disclosed funding, and public evidence of its customer base beyond the handful of named accounts is limited.